臨床血液學(xué)檢驗(yàn)技師考試急性髓細(xì)胞白血病練習(xí)題8958

2018

A1

1

M

3

,

,

,(;),

a

ACD13CD33HLA-DRt1517PML-RA

BCD13CD33t821AML1/ETO

CCD13CD33inv16CBFB/MYH11

DCD41+CD33t122

ECD13CD33t69DEK-KLAE

2

M

At

821

922

B

t

Ct1517

Dt69

E

3

11

t

19

M

b

At

821q22q22

B

t

11

q23

Ct922q34

q11

Dt814q24q32

E

69p23q34

t

4AML-M

a

APOX

BPAS

CNAP

DAS-D-NAE

5Auer

NaF

AALL

BCML

CAML-M

3

DAML-M

0

EAML-M7

6

Mb

APML-RARc

BCBFB-MYH11

CMLL-ENL

Dbcr-abl

EAML1

1

7

AML-M

1

t15

t8

q2q21

q22q22

q34q22

A

7

2

B

21

22

Ct9

Dt8

14q24q32

E

8

(P13

inv16

AML-Mq

|22

ADEK-CAN

BPML-RAa

CPLEF-RARx

DBcr/abl

ENPM-RAR

9

APML-RAa

B

C

D

Auer

EM

10

PAS

A

B

C

D

E

-

11AML-M

A

B

C

D

E

12AML-MPOX

I

A

B

3%

5%

C10%

D30%

E

50%

13

FAB

M

NEC

a

2

A10%~30%

B20%79%

C30%~89%

D30%-80%

E40%70%

14AML-MPOX

A

B

C

D

E

15AML-M

a

PAS

A

B

C

D

E

16AML-M

a

NAP

A

B

C

D

E

17AML-M2b

A

B

C

D

E

18

DIC

AAML-M

BAML-M

CAML-ME

DCML

EALL

19

AML-M

a

A-

3

BAS-D-NAE

CAS-D-NAE

DPOX

EPOX

20

AML-ME

A

B

C

D

E

21

AML-M

A

B

C

D

E

22AML-M

A

B

C

D

E

23AML-M

NaF

A

B

C

D

E

24AML-M

APAS

BPOX

C

NaF

NaF

DSBB

E

25AML-M

a

A

B

4

C

D

E

26AML-M

b

v

A30%

B

V40%

v

C60%

v

D70%

v

E80%

27AML-M

NEC

a

A

B

30%

50%

C60%

D80%

E

90%

28AML-M

A

BHowell-Jolly

C

D

E

29AML-M

A

B

C

D

E

30AML-M

APAS

BPOX

CPAS

DSBB

E

31AML-M

APAS

B5-

CACP

5

DSBB

EMPC

B

6

1A.t814

B.t922

C.t1418

D.t1517

E.t1114

<1>

ABCDE

2A.

B.

C.

D.

E.

<1>

ABCDE

<2>

ABC

D

D

E

E

<3>

ABC

3A.

B.

C.

50%

D.

30%NEC

E.

NEC

E

90%

<1>

ABC

<2>

D

D

D

M

ABC

<3>

E

M

E

ABC

4A.del14q22q23

B.t922q34q11

C.t814q24q32

D.t821q22q22

E.t1517q22q12

<1>CML

ABC

<2>HCL

ABC

<3>AML-M

ABC

<4>AML-M

D

D

D

D

E

E

E

E

ABC

7

A1

1

A

M3

CD13CD33MPOCD68

t1517

HLA-DRCD34

t1517

70%-90%APL

17

PMI

APL

aRAR%

15

PML-RAF

2

3

4

C

M

t1517

A

t821q22q22

Mb

90%

B

M2a

POXSB

NAP

AS-D

AS-D-NAB

5

C

M3

9

X

1510/L

90%Auer

6

7

&

E

M2b

AML1

B

AML-M2

t821q22q22

B

70%-90%APL

t1517

APL

a

RARx

t1517

17

15

9

PML

PML-RAF

PML-RAF

A

70%90%APL

t1517

APL

a

RARx

t1517

17

15

10

PML

C

D

PAS

11

8

AML-M

A

i

12

13

14

15

16

17

18

AML-MPOX

i

3%

C

FAB

M

a

NEC30%-89%

A

AML-MPOX

2

B

AML-M

2a

PAS

E

AML-M

2a

NAP

C

AML-M2b

30%NEC。

B

M

APL

19

20

D

AML-M

POXSBAS-D-NCEACP

AS-D-NAE

3

a-

A

AML-M

4&

5%30%

21

22

23

B

AML-M

4

A

AML-M

CD13CD14CD33HLA-DR

CD9

4

9

E

AML-M

4

NaF

NaF

24

10

C

AML-M

NaF

5

25

26

27

C

AML-M

80%(NEC。

5a

5b

5a

E

AML-M

80%

D

AML-M

NEC

80%

2&

29

A

M

6

D

AML-M

6

30

31

C

AML-M

PAS

6

B

AML-M

5-

ACRPAS

NaF

ANAE

7

MPOSB

D

1

2

ARL

70%^90%ARL

t15

B

A

C

11